Investigation next-generation antibiotics continues with ERC grant Nathaniel Martin

25 May 2022

Nathaniel Martin has received the Proof of Concept (PoC) grant. The European Research Council (ERC) awarded Martin this grant to continue his research on reducing the toxicity of the antibiotic polymyxin: A potent medicine, but with severe side effects. He receives €150.000.

The professor of Biological Chemistry of the Institute Biology Leiden (IBL) of Leiden University has already developed new polymixins. Using a semi-synthetic approach, his group has now reduced the toxicity. However, further testing is necessary to assess the extent of its use on multi-drug resistant bacteria.

Read the complete article here.